INSIGHTS ON CLINICAL TRIAL PARTNERING

• Why Biotech CRO Partnerships Are Essential For Clinical Trial Success

  For early-stage biotech companies, the road from discovery to market is fraught with challenges, and in this environment, strategic partnerships with CROs have become a cornerstone of clinical success.

• In-Vivo CAR Therapies — Global Research And Development Landscape

  Delve into the evolving in-vivo CAR therapy landscape, examining key technological innovations, major industry players, recent clinical progress, and regulatory developments.

• Why Flexible Payment Options Matter For Clinical Trial Participants

  In clinical trials, offering a variety of payment options is critical for participant retention and overall study success. How can you make the payment process simple and flexible?

• AI-Powered Strategy Is Redefining Patient Recruitment Performance

  This AI-powered platform is helping CROs and sponsors tackle the unsolved challenge they've faced for decades: clinical trials that launch late, recruit slowly, and miss enrollment targets.

• How To Unlock The Secret To Repeatable, Scalable Low Turnover

  6/7/2024

  Here, we explore the evolution of a 10-year partnership and extrapolate the principles that create cohesive teams and minimize turnover.

• Reducing Time To First-In-Human Trials With Robotic SFF Services

  6/21/2024

  Discover how robotic gloveless isolator sterile fill-finish (SFF) systems can accelerate early-phase drug development, ensuring enhanced sterility and streamlined processes for biopharma innovation.

• The Hidden Cost Of Transactional Burden: It's Time For Sites To Speak Up

  9/3/2025

  Transactional burdens weigh heavily on sites, straining trust with sponsors and patients. See why site voices matter and how sounding off can strengthen clinical trial relationships.

• Tips And Tricks For Developing Rare Cancer Clinical Trials

  2/6/2025

  Conducting clinical trials for rare cancers presents unique challenges, making a partnership with an experienced Oncology CRO crucial for overcoming hurdles and ensuring trial success.

• Clinical Trials In The Age Of Cost Caps

  4/14/2025

  On February 7, 2025, the NIH introduced a pivotal policy (NOT-OD-25-068), capping indirect cost recovery at 15% for research grants.